Please try another search
Aposense Ltd., a biopharmaceutical company, engages in the development of novel drugs based on proprietary integration of structural and electrical properties of biological membranes. It develops molecular nano-motors that are small-chemical entities capable of energy mining from the intra-membrane electric field. Its Apo-Si is a platform technology for the delivery of genetic drugs, such as siRNA into cells. It is involved in the development of ATT-11T, which is a conjugate of proprietary molecular nano-motor with SN-38, the active moiety of irinotecan for the treatment of solid tumors. Aposense Ltd. has a research collaboration with Bioasis Technologies Inc. to focus on the delivery of siRNA into the brain. The company was formerly known as N.S.T. Neuro Sauriol Technologies Ltd. and changed its name to Aposense Ltd. in August 2008. Aposense Ltd. was founded in 1996 and is based in Petah Tikva, Israel.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review